ArticleFrontiers in cell and developmental biology2026
Divergent roles of circMPP6 and its parental gene MPP6 in non-small cell lung cancer.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Upregulation of a CircularInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Circular RNAs (circRNAs) regulate cancer biology, but their relationships with parental genes remain unclear. We characterized circMPP6, derived from MPP6, and its interplay with MPP6 in non-small cell lung cancer (NSCLC). Methods: circMPP6 was validated by RNase R resistance and Sanger sequencing in A549 cells. Expression of circMPP6 and MPP6 was measured in 10 paired NSCLC tumors and adjacent-tissues. RNA-seq after gain-of-function of circMPP6, MPP6, and SLC7A11 was followed by enrichment analyses and chromosome-level DEG mapping. Proliferation was assessed by CCK-8 and xenografts. Lactate and glutathione were quantified, SLC7A11 protein measured by Western blot, and prognosis analyzed in GEO/TCGA. Results: MPP6 trended upward in tumors, while circMPP6 was unchanged. circMPP6 and MPP6 were positively correlated in adjacent-tissues but not in tumors. Overexpression of circMPP6 and MPP6 yielded 765 and 334 DEGs, respectively, with shared enrichment of hypoxia-related pathways. 67 genes were upregulated by circMPP6 but downregulated by MPP6, also linked to hypoxia signaling. circMPP6-regulated DEGs were enriched on chromosome 19, whereas MPP6-regulated DEGs clustered on chromosome 17. Functionally, circMPP6 did not alter proliferation, MPP6 enhanced it, and co-expression attenuated MPP6-driven growth Conclusion: circMPP6 and MPP6 exert distinct, partially opposing effects on NSCLC growth. In the context of MPP6 overexpression, circMPP6 counteracts tumor-promoting programs, highlighting functional divergence between circRNAs and their parental genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.